Hydroxycarbazepine distribution in three postmortem cases

Journal of Analytical Toxicology

Volumn 28, Issue 6, 2004, Pages 509-511

  Levine, Barry ^a   Green Johnson, Deborah ^a   Moore, Karla A ^a   Fowler, David R ^a  

^a OFFICE OF THE CHIEF MEDICAL EXAMINER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; CYCLOBENZAPRINE; DRUG METABOLITE; LICARBAZEPINE; MORPHINE; NORDAZEPAM; OXCARBAZEPINE; OXYCODONE; SERTRALINE;

CADAVER; CASE REPORT; CAUSE OF DEATH; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG INTOXICATION; DRUG METABOLISM; GAS CHROMATOGRAPHY; HUMAN; SEIZURE; SUICIDE;

EID: 4344562805     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.6.509     Document Type: Conference Paper

References (6)

1. S. Schachter. The new wave of anticonvulsants-focus on levetiracetam, oxcarbazepine and zonisamide. CNS Drugs 14: 229-249 (2000).
2. A. Sabres and L. Gram. Newer anticonvulsants-comparative review of drug interactions and adverse effects. Drugs 60: 23-33 (2000).
3. A.D. Fraser and A.J. Jenkins. Recent advances in drug therapy for the treatment of epilepsy. In Therapeutic Drug Monitoring and Toxicology Education, Vol. 17. American Association for Clinical Chemistry, Washington, D.C., 1996, pp 91-102.
4. R.W. Prouty and W.H. Anderson. The forensic science implications of site and temporal influences on postmortem blood drug concentrations. J. Forensic Sci. 35: 243-270 (1990).
5. M. Dalpe-Scott, M. Degouffe, D. Garbutt, and M. Drost. A comparison of drug concentrations in postmortem cardiac and peripheral blood in 320 cases. Can. Soc. Forensic Sci. J. 28: 113-121 (1995).
6. M. Klys, B. Bystrowska, and B. Bujak-Gizycka. Postmortem toxicology of carbamazepine. J. Anal. Toxicol. 27: 243-248 (2003).